gvtcx

supplier · GB-PPONPZNC-1575-PCQX

Takeda UK Limited

W26BD combined from 3 published records

Takeda UK Limited has won 80 UK public sector awards from 11 buyers since 2018. The typical award is worth £240,457,500.

as a supplier

80 recorded awards from 11 buyers , between 8 Jan 2018 and 26 Aug 2026.

awards won
80
exclusive
16%
13 sole-winner awards
median award
£240.5m
largest
£986.3m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

common questions about Takeda UK Limited

How many public sector contracts has Takeda UK Limited won?

Takeda UK Limited has won 80 UK public sector contracts from 11 public bodies since 2018.

Which public bodies buy from Takeda UK Limited?

Takeda UK Limited has won the most contracts from NHS England, The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") and NHS England.

How large are Takeda UK Limited's contracts?

The median published value of a contract won by Takeda UK Limited is £240,457,500. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.

Which Takeda UK Limited contracts are expiring soon?

6 contracts involving Takeda UK Limited have end dates in the next 12 months, the earliest on 31 Dec 2026.

contracts expiring in the next 12 months

Contract end dates as published on the original notice. An end date is not a commitment to re-tender — a contract may be extended, varied or allowed to lapse — but it is the earliest public signal that work may come back to market.

contracts won

contractbuyervalueawarded
NHS National Generic Pharmaceuticals - Wave 16a shared NHS England £393,331,872 26 Aug 2026
NHS National Branded Interim - 1 June 2026 shared NHS England £529,090,780 9 Apr 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £403,702,000 13 Jan 2026
NHS National Generic Pharmaceuticals - Wave 15c shared NHS England £37,160,000 13 Jan 2026
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 shared NHS England £986,282,758 30 Jun 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared NHS England £1,241,520,444 24 Mar 2025
NHS Framework Agreement for the supply of licenced Human Albumin Solution & Normal and Anti-D Immunoglobulins shared NHS England £905,187,090 19 Dec 2024
NHS Branded Medicines Tranche Framework for London and South of England shared NHS England £380,950,720 21 Jul 2024
NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 shared NHS England £765,000,000 30 May 2024
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 shared NHS England £1,009,500,000 4 Apr 2024
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2) shared NHS England £1 4 Mar 2024
NHS South of England Branded Medicines - Tranche A - September 2023 shared NHS ENGLAND £249,832,000 17 Jul 2023
NHS London Branded Medicines - Tranche B - September 2023 shared NHS ENGLAND £231,083,000 13 Jul 2023
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared NHS England £304,504,000 23 Apr 2023
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023
NHS National Generic Pharmaceuticals Wave 14a shared NHS England £207,982,407 14 Dec 2022
NHS National Pharmaceuticals Transition 2022_2 shared NHS England £35,745,737 1 Nov 2022
NHS Framework Agreement for South of England Branded - Tranche B and Annual shared NHS England £338,655,597 14 Jul 2022
NHS Framework Agreement for London, Branded Medicines - Tranche A and Annual shared NHS England £153,778,681 14 Jul 2022
Hereditary Angioedema shared NHS England £74,500,000 19 Jun 2022
Bleeding Disorders including Haemophilia B shared NHS England £250,000,000 14 Jun 2022
NHS Framework Agreement for Branded Medicines - National shared NHS England £526,000,000 15 May 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022

every contract won by Takeda UK Limited →

as published

This page combines 3 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Takeda UK Ltd · W2 6BD 75
TAKEDA UK LIMITED GB-PPON PZNC-1575-PCQX W2 6BD 4
Takeda UK Ltd GB-COH 03362680 HP10 0DF 1

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works

where these figures come from

Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 13 Sept 2026 and is refreshed from the publishers' own APIs through the working day.

Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations. The 3 published records behind this page are listed above exactly as filed, so any merge can be checked.

Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works

Contains public sector information licensed under the Open Government Licence v3.0.